Heterocyclic compounds having anti-HBV activity
US7465742B2 · kind B2 · utility
1Cited by
1References
28Claims
0Family size
Inventors
Key dates
| Filing date | Feb 3, 2006 |
| Grant date | Dec 16, 2008 |
| Priority date | — |
| Expiry date | Mar 27, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This application relates to novel fused tricyclic thienopyridines of Formulas I and II, which useful for treating Hepatitis B infection and other diseases.This application also relates to pharmaceutical compositions comprising thienopyridines and to the use of such compositions to treat Hepatitis B and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.